TRAW - Traws Pharma, Inc.
1.41
-0.080 -5.674%
Share volume: 30,569
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.49
-0.08
-0.05%
View ratios
Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | |
Total revenue | 56.000 K | 57.000 K | 57.000 K | |
Cost of revenue | 0.000 | 0.000 | 0.000 | |
Gross profit | 56.000 K | 57.000 K | 57.000 K | |
1.79% | 0.00% | |||
Operating expenses | 5.268 M | 123.405 M | 8.593 M | |
Selling general and admin | 3.356 M | 1.977 M | 3.480 M | |
Research and development | 1.912 M | 121.428 M | 5.113 M | |
Total expenses | 5.268 M | 123.405 M | 8.593 M | |
2,242.54% | -93.04% | |||
Operating income | -5.212 M | -123.348 M | -8.536 M | |
Ebit | -4.983 M | -123.143 M | -8.475 M | |
Pretax income | -4.983 M | -123.143 M | -8.475 M | |
2,371.26% | -93.12% | |||
Income tax | 0.000 | 0.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | |
Net income | -4.983 M | -123.143 M | -8.475 M | |
-2,371.26% | 93.12% |